VIRAL SUPPRESSION AT WEEK 4 EXCEEDS THE IL28B SNP FOR PREDICTING SVR IN PEGYLATED INTERFERON PLUS RIBAVIRIN COMBINATION THERAPY OF GENOTYPE 1 INFECTED PATIENTS WITH CHRONIC HEPATITIS C

被引：0

作者：

Oze, Tsugiko ^{[1
]}

Hiramatsu, Naoki ^{[1
]}

Yakushijin, Takayuki ^{[1
]}

Doi, Yoshinori ^{[2
]}

Ogawa, Hiroyuki ^{[3
]}

Hagiwara, Hideki ^{[4
]}

Mita, Eiji ^{[5
]}

Kaneko, Akira ^{[6
]}

Katayama, Kazuhiro ^{[7
]}

Hijioka, Taizo ^{[8
]}

Tamura, Shinji ^{[9
]}

Yoshihara, Harumasa ^{[10
]}

Inoue, Atsuo ^{[11
]}

Imai, Yasuharu ^{[12
]}

Hayashi, Eijirou ^{[13
]}

Hosui, Atsushi ^{[1
]}

Miyagi, Takuya ^{[1
]}

Yoshida, Yuichi ^{[1
]}

Tatsumi, Tomohide ^{[1
]}

Kiso, Shinichi ^{[1
]}

Kanto, Tatsuya ^{[1
]}

Kasahara, Akinori ^{[1
]}

Hayashi, Norio ^{[4
]}

Takehara, Tetsuo ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan

[2] Otemae Hosp, Osaka, Japan

[3] Nishinomiya Municipal Cent Hosp, Nishinomiya, Hyogo, Japan

[4] Kansai Rousai Hosp, Amagasaki, Hyogo, Japan

[5] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan

[6] NTT W Osaka Hosp, Osaka, Japan

[7] Natl Hosp Org Osaka Minami Med Ctr, Kawachi Nagano, Japan

[8] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan

[9] Minoh City Hosp, Mino, Japan

[10] Osaka Rosai Hosp, Sakai, Osaka, Japan

[11] Osaka Gen Med Ctr, Osaka, Japan

[12] Ikeda Municipal Hosp, Ikeda, Osaka, Japan

[13] Mutual Aid Assoc Publ Sch Teacher, Kinki Cent Hosp, Itami, Hyogo, Japan

来源：

HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：852A / 853A

页数：2

共 50 条

[31] Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus
Pineda, Juan A.
Caruz, Antonio
Rivero, Antonio
Neukam, Karin
Salas, Irene
Camacho, Angela
Palomares, Jose C.
Mira, Jose A.
Martinez, Antonio
Roldan, Carmen
de la Torre, Julian
Macias, Juan
CLINICAL INFECTIOUS DISEASES, 2010, 51 (07) : 788 - 795
[32] IL28B genotype is not useful for predicting pegylated-interferon-α treatment outcome in Asian chronic hepatitis B cohorts
Holmes, Jacinta A.
Tin Nguyen
Ratnam, Dilip
Heerasing, Neel M.
Tehan, Jane V.
Chen, Robert
Dev, Anouk
Bell, Sally
Pianko, Stephen
Bonanzinga, Sara
Visvanathan, Kumar
Rusli, Ferry
Locarnini, Stephen
Sievert, William
Bowden, D. Scott
Desmond, Paul
Thompson, Alex
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 166 - 167
[33] Impact of IL28B gene polymorphisms rs8099917 and rs12980275 on response to pegylated interferon-α/ribavirin therapy in chronic hepatitis C genotype 4 patients
Mahmoud A Khattab
Hend M Abdelghany
Maggie M Ramzy
Rasha M Khairy
The Journal of Biomedical Research, 2016, 30 (01) : 40 - 45
[34] Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors
Kurosaki, Masayuki
Tanaka, Yasuhito
Nishida, Nao
Sakamoto, Naoya
Enomoto, Nobuyuki
Honda, Masao
Sugiyama, Masaya
Matsuura, Kentaro
Sugauchi, Fuminaka
Asahina, Yasuhiro
Nakagawa, Mina
Watanabe, Mamoru
Sakamoto, Minoru
Maekawa, Shinya
Sakai, Akito
Kaneko, Shuichi
Ito, Kiyoaki
Masaki, Naohiko
Tokunaga, Katsushi
Izumi, Namiki
Mizokami, Masashi
JOURNAL OF HEPATOLOGY, 2011, 54 (03) : 439 - 448
[35] Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C
Staettermayer, A. F.
Strassl, R.
Maieron, A.
Rutter, K.
Stauber, R.
Strasser, M.
Beinhardt, S.
Datz, C.
Scherzer, T. -M.
Steindl-Munda, P.
Gschwantler, M.
Trauner, M.
Hofer, H.
Ferenci, P.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (01) : 104 - 111
[36] Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C
Martinot-Peignoux, M.
Comanor, L.
Minor, J. M.
Ripault, M. P.
Pham, B. -N.
Boyer, N.
Castelnau, C.
Giuily, N.
Hendricks, D.
Marcellin, Patrick
JOURNAL OF VIRAL HEPATITIS, 2006, 13 (10) : 701 - 707
[37] IMPORTANCE OF HOST GENETIC FACTOR, HLA AND IL28B, AS PREDICTORS OF RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C
Munoz de Rueda, Paloma
Lopez-Nevot, MAngel
Saenz Lopez, Pablo
Casado, Jorge
Maria Martin-Casares, Antonia
Palomares, Pablo
Quiles, Rosa
Gila, Ana
Romero-Gomez, Manuel
Jose Pavon, Esther
Munoz-Gámez, Jose Antonio
Carazo, Angel
Sanz-Cameno, Paloma
Moreno-Otero, Ricardo
Diago, Moises
Palacios, Angel
Ruiz-Extremera, Angeles
Salmeron, Javier
HEPATOLOGY, 2010, 52 (04) : 786A - 786A
[38] Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin A Randomized Study
Yeh, Ming-Lun
Hsieh, Ming-Yen
Huang, Ching-I.
Huang, Chung-Feng
Hsieh, Meng-Hsuan
Liang, Po-Cheng
Lin, Yi-Hung
Hou, Nai-Jen
Lin, Zu-Yau
Chen, Shinn-Cherng
Huang, Jee-Fu
Dai, Chia-Yen
Chuang, Wan-Long
Yu, Ming-Lung
MEDICINE, 2015, 94 (42) : e1837
[39] Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy
Hsu, Ching-Sheng
Hsu, Shih-Jer
Chen, Hung-Chia
Tseng, Tai-Chung
Liu, Chen-Hua
Niu, Wei-Fang
Jeng, Jenher
Liu, Chun-Jen
Lai, Ming-Yang
Chen, Pei-Jer
Kao, Jia-Horng
Chen, Ding-Shinn
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (09) : 3719 - 3724
[40] Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With PEGylated Interferon Plus Ribavirin: A Randomized Study
Yeh, M. L.
Huang, C. F.
Huang, C. I.
Hsieh, M. Y.
Huang, J. F.
Dai, C. Y.
Chuang, W. L.
Yu, M. L.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : 1384 - 1384

← 1 2 3 4 5 →